 Amber Podoll
Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 10 | 2015 | 875 | 1.350 |
Why?
| | Renal Replacement Therapy | 2 | 2009 | 100 | 0.560 |
Why?
| | Critical Illness | 3 | 2013 | 900 | 0.480 |
Why?
| | Urinary Bladder Neck Obstruction | 1 | 2013 | 19 | 0.390 |
Why?
| | Bioartificial Organs | 1 | 2012 | 3 | 0.380 |
Why?
| | Liver, Artificial | 1 | 2012 | 5 | 0.380 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2013 | 288 | 0.340 |
Why?
| | Nephrology | 1 | 2012 | 60 | 0.340 |
Why?
| | Statistics as Topic | 1 | 2012 | 283 | 0.330 |
Why?
| | Ultrasonography | 1 | 2013 | 785 | 0.300 |
Why?
| | Acid-Base Imbalance | 1 | 2009 | 3 | 0.290 |
Why?
| | Evidence-Based Medicine | 2 | 2014 | 740 | 0.280 |
Why?
| | Embolism | 1 | 2009 | 48 | 0.280 |
Why?
| | Water-Electrolyte Imbalance | 1 | 2009 | 42 | 0.280 |
Why?
| | Hypotension | 1 | 2009 | 127 | 0.270 |
Why?
| | Blood Pressure Determination | 1 | 2007 | 145 | 0.240 |
Why?
| | Nutritional Status | 1 | 2008 | 353 | 0.230 |
Why?
| | Diagnostic Errors | 1 | 2007 | 178 | 0.230 |
Why?
| | Biomedical Research | 1 | 2012 | 717 | 0.220 |
Why?
| | Wounds and Injuries | 1 | 2013 | 961 | 0.220 |
Why?
| | West Nile virus | 2 | 2017 | 41 | 0.220 |
Why?
| | West Nile Fever | 2 | 2017 | 57 | 0.210 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2017 | 668 | 0.210 |
Why?
| | Texas | 4 | 2017 | 272 | 0.200 |
Why?
| | Antigens, CD19 | 1 | 2024 | 128 | 0.200 |
Why?
| | Practice Guidelines as Topic | 2 | 2014 | 1581 | 0.200 |
Why?
| | Plasma Exchange | 2 | 2014 | 18 | 0.200 |
Why?
| | Ambulatory Care | 1 | 2007 | 609 | 0.180 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2930 | 0.170 |
Why?
| | Kidney | 5 | 2017 | 1497 | 0.160 |
Why?
| | Immunotherapy, Adoptive | 1 | 2024 | 342 | 0.160 |
Why?
| | Lupus Nephritis | 1 | 2020 | 67 | 0.160 |
Why?
| | Autoimmune Diseases | 1 | 2024 | 468 | 0.160 |
Why?
| | Cyclophosphamide | 1 | 2020 | 270 | 0.150 |
Why?
| | Incidence | 3 | 2013 | 2923 | 0.150 |
Why?
| | Rituximab | 1 | 2020 | 210 | 0.150 |
Why?
| | Hospitalization | 1 | 2009 | 2460 | 0.150 |
Why?
| | Hypertension | 1 | 2007 | 1273 | 0.140 |
Why?
| | Risk Factors | 6 | 2017 | 10885 | 0.140 |
Why?
| | T-Lymphocytes | 1 | 2024 | 1996 | 0.120 |
Why?
| | Immunosuppressive Agents | 1 | 2020 | 838 | 0.120 |
Why?
| | Primary Myelofibrosis | 1 | 2015 | 8 | 0.110 |
Why?
| | Comorbidity | 2 | 2013 | 1661 | 0.110 |
Why?
| | Glomerulonephritis, Membranoproliferative | 1 | 2015 | 25 | 0.110 |
Why?
| | Intensive Care Units | 2 | 2013 | 924 | 0.110 |
Why?
| | Proteinuria | 1 | 2015 | 104 | 0.110 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2020 | 992 | 0.100 |
Why?
| | Protective Agents | 1 | 2014 | 42 | 0.100 |
Why?
| | Myoglobin | 1 | 2013 | 12 | 0.100 |
Why?
| | Hemofiltration | 1 | 2013 | 24 | 0.100 |
Why?
| | Humans | 17 | 2024 | 145475 | 0.100 |
Why?
| | Trauma Severity Indices | 1 | 2013 | 115 | 0.100 |
Why?
| | Causality | 1 | 2013 | 126 | 0.090 |
Why?
| | Sorption Detoxification | 1 | 2012 | 2 | 0.090 |
Why?
| | Dialysis | 1 | 2012 | 19 | 0.090 |
Why?
| | Extracorporeal Circulation | 1 | 2012 | 14 | 0.090 |
Why?
| | Prevalence | 3 | 2017 | 2865 | 0.090 |
Why?
| | Patient Outcome Assessment | 1 | 2013 | 130 | 0.090 |
Why?
| | Middle Aged | 8 | 2024 | 36215 | 0.090 |
Why?
| | Albumins | 1 | 2012 | 119 | 0.090 |
Why?
| | Liver Failure | 1 | 2012 | 83 | 0.090 |
Why?
| | Pyrazoles | 1 | 2015 | 517 | 0.080 |
Why?
| | Multiple Myeloma | 1 | 2014 | 309 | 0.080 |
Why?
| | Male | 10 | 2024 | 72843 | 0.080 |
Why?
| | Renal Dialysis | 1 | 2014 | 466 | 0.080 |
Why?
| | Kidney Function Tests | 1 | 2009 | 156 | 0.070 |
Why?
| | Female | 9 | 2024 | 78845 | 0.070 |
Why?
| | Protein Kinase Inhibitors | 1 | 2015 | 981 | 0.070 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1997 | 0.070 |
Why?
| | Creatinine | 1 | 2009 | 515 | 0.070 |
Why?
| | Adult | 6 | 2024 | 40777 | 0.060 |
Why?
| | Cholesterol | 1 | 2008 | 408 | 0.060 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2008 | 317 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3413 | 0.060 |
Why?
| | Health Care Surveys | 1 | 2007 | 536 | 0.060 |
Why?
| | Hospital Mortality | 1 | 2009 | 1038 | 0.050 |
Why?
| | Cohort Studies | 2 | 2017 | 6013 | 0.040 |
Why?
| | Retrospective Studies | 2 | 2013 | 17291 | 0.040 |
Why?
| | Aged | 4 | 2024 | 26153 | 0.040 |
Why?
| | Treatment Outcome | 4 | 2020 | 11772 | 0.040 |
Why?
| | Prognosis | 1 | 2009 | 4316 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2024 | 673 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 14219 | 0.040 |
Why?
| | Adolescent | 3 | 2024 | 22530 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2020 | 260 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2020 | 1044 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 2017 | 414 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2007 | 6447 | 0.030 |
Why?
| | Uromodulin | 1 | 2014 | 22 | 0.030 |
Why?
| | Immunoglobulin Light Chains | 1 | 2014 | 52 | 0.030 |
Why?
| | Nitriles | 1 | 2015 | 207 | 0.030 |
Why?
| | Myoglobinuria | 1 | 2013 | 1 | 0.030 |
Why?
| | Oliguria | 1 | 2013 | 2 | 0.030 |
Why?
| | Rhabdomyolysis | 1 | 2013 | 24 | 0.020 |
Why?
| | Obesity | 1 | 2007 | 3116 | 0.020 |
Why?
| | Infant | 1 | 2007 | 10077 | 0.020 |
Why?
| | Acute-Phase Proteins | 1 | 2012 | 66 | 0.020 |
Why?
| | Lipocalins | 1 | 2012 | 35 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2012 | 112 | 0.020 |
Why?
| | Lipocalin-2 | 1 | 2012 | 80 | 0.020 |
Why?
| | Child, Preschool | 1 | 2007 | 11853 | 0.020 |
Why?
| | Pyrimidines | 1 | 2015 | 530 | 0.020 |
Why?
| | Prospective Studies | 2 | 2013 | 8057 | 0.020 |
Why?
| | Animals | 1 | 2012 | 38030 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2012 | 624 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 1061 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1547 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2012 | 765 | 0.020 |
Why?
| | Logistic Models | 1 | 2012 | 2134 | 0.020 |
Why?
| | Child | 1 | 2007 | 22707 | 0.020 |
Why?
| | Time Factors | 1 | 2013 | 7123 | 0.010 |
Why?
|
|
Podoll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|